fluorodopa f 18 has been researched along with Necrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozzao, A; Cicone, F; Maurizi Enrici, R; Minniti, G; Papa, A; Romano, A; Scaringi, C; Scopinaro, F; Tavanti, F | 1 |
| Airas, L; Marttila, RJ; Paavilainen, T; Rinne, JO; Rissanen, E; Virta, J | 1 |
| Imahori, Y; Kawano, H; Misawa, A; Sawada, T; Takeuchi, Y | 1 |
3 other study(ies) available for fluorodopa f 18 and Necrosis
| Article | Year |
|---|---|
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Postoperative Period; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).
Topics: Adult; Basal Ganglia Diseases; Carbon Monoxide Poisoning; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Functional Laterality; Globus Pallidus; Humans; Magnetic Resonance Imaging; Necrosis; Nerve Fibers, Myelinated; Positron-Emission Tomography; Putamen; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Substantia Nigra | 2010 |
Putaminal necrosis presenting with hemidystonia.
Topics: Antiparkinson Agents; Brain Diseases; Child; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Necrosis; Putamen; Tomography, Emission-Computed; Treatment Outcome | 2000 |